And the prognostic analysis showed that only HCC patients with high levels of hsa-miR-125b-5p (the upstream miRNA of GLS and CDKN2A) (Figure 7C, P = 2.0e-18) had better overall survival (Figure 7C, P = 0.037). This evidence concerns the gene CDKN2A and hepatocellular carcinoma.